Network origin in Mike Stachura first degree
Entity | Entity type | Industry | |
---|---|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY.
11
| Subsidiary | Biotechnology | 11 |
PSC, Inc. /Old/
3
| Extinct | Electronics Distributors | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mike Stachura via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Rochester Christian University | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
EASTMAN KODAK COMPANY | Industrial Machinery | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Administrative Officer Director/Board Member | |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Operating Officer | |
AMYRIS, INC. | Chemicals: Specialty | Corporate Officer/Principal | |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Medical Specialties | Corporate Officer/Principal | |
Noden Pharma USA, Inc.
Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | Electronic Equipment/Instruments | Director/Board Member | |
George Washington University Law School | College/University | Graduate Degree | |
LS Dissolution, Inc.
LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | General Counsel | |
Willian Brinks Hofer Gilson & Lione Ltd. | Corporate Officer/Principal | ||
International N&H Denmark ApS
International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Corporate Officer/Principal | |
Nevada Bar Association | Corporate Officer/Principal | ||
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer | |
University of Massachusetts | College/University | Undergraduate Degree | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
REGENXBIO INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Purdue University | College/University | Doctorate Degree | |
Novo-Nordisk Biochem, Inc. | Corporate Officer/Principal | ||
The University of Arkansas | College/University | Corporate Officer/Principal | |
University of California, Berkeley | College/University | Doctorate Degree | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Clarkson College | College/University | Undergraduate Degree | |
Clarkson University | College/University | Graduate Degree | |
Trillium Group LLC
Trillium Group LLC Investment ManagersFinance Trillium Group LLC (Trillium Group) is a venture capital firm founded in 1997 by Daniel Berg. The firm is headquartered in Pittsford, New York. | Investment Managers | Private Equity Investor | |
Michigan Biotechnology Institute | Corporate Officer/Principal | ||
TATE & LYLE PLC | Food: Specialty/Candy | Chief Tech/Sci/R&D Officer | |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
National Response Corp.
National Response Corp. Environmental ServicesIndustrial Services National Response Corp provides environmental, industrial, and emergency solutions. Its services include responsive, industrial, remediation, marine, consultancy, and training solutions. It offers pre-contracted oil spill removal coverage to vessels of all types and also covers assorted terminals, refineries, utilities, offshore exploration and production platforms, pipelines, and airports. The company was founded in 1992 and is headquartered in Great River, NY. | Environmental Services | Chief Executive Officer | |
Precision Source LLC | Corporate Officer/Principal | ||
Worcester State University | College/University | Undergraduate Degree | |
LANNETT COMPANY, INC. | Pharmaceuticals: Major | Director/Board Member | |
A&D Environmental Services, Inc.
A&D Environmental Services, Inc. Environmental ServicesIndustrial Services A&D Environmental Services, Inc. provides environmental waste cleaning and removal services. Its services include industrial, waste management, remediation, emergency response, and transportation services. The company was founded in 1992 and is headquartered in High Point, NC. | Environmental Services | Chief Executive Officer | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Universität Leipzig | College/University | Doctorate Degree | |
Amunix, Inc.
Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | Director/Board Member | |
CRISPR THERAPEUTICS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SWEET NATURAL TRADING CO. LIMITED | Food: Specialty/Candy | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal |
Statistics
International
United States | 46 |
Denmark | 2 |
United Kingdom | 2 |
Germany | 2 |
Switzerland | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 12 |
Process Industries | 4 |
Consumer Non-Durables | 4 |
Commercial Services | 3 |
Operational
Corporate Officer/Principal | 44 |
Director/Board Member | 37 |
President | 13 |
Undergraduate Degree | 11 |
Chief Tech/Sci/R&D Officer | 11 |
Most connected contacts
- Stock Market
- Insiders
- Mike Stachura
- Company connections